Acquisition - May 8, 2022
Prevas acquires BitSim NOW
Prevas has signed an agreement for the acquisition of 100 percent of BitSim NOW AB, a subsidiary of Vironova. BitSim NOW is a consulting firm in Stockholm with 35 employees focusing on innovative product development. Examples of areas of strength are digital cameras, image processing and vision technology as well as FPGA circuit development. Customers […]
Financing - November 27, 2017
Vironova awarded funding for AI and machine learning
Vironova has been awarded funding for a two-year research project entitled “Interactive visualization tools for verification and improvement of deep neural network predictions.” The project will stretch over two years (Jan 2018- Dec 2019) and represents a collaboration of strategical importance to Vironova in the areas of Artificial Intelligence (AI) and Machine Learning, applied to […]
Intellectual Property - April 21, 2017
Vironova awarded US patent for further automation of TEM
Vironova has been granted a US patent with the title “A method for automatic correction of astigmatism”. Their method removes a manual step that requires considerable operator skill. It can be applied to any electron microscope, allowing for automated correction of the electron beam and ultimately enabling fully automated image acquisition. An important feature of […]
Collaboration - March 1, 2017
Vironova participate in big data and computational science project
Vironova is participating in the research project “Hierarchical Analysis of Temporal and Spatial Image Data” which the Swedish foundation for Strategic Research (SSF) has announced 29 M SEK in funding for. Other partners in the project are Astra Zeneca and SciLifeLab and the project is headed by Professor Carolina Wählby at Uppsala University Department of […]
Agreement - February 27, 2017
Vironova signs agreement with the FDA
Vironova signs one-year agreement with the U.S. Food and Drug Administration to beta test proprietary Vironova Analyzing Software (VAS). In one of the fastest growing drug development areas today, nano-particles (for example liposomes), visible using electron microscopy, are used to deliver drugs to their exact targets in the body. Vironova Analyzing Software (VAS) in combination […]
Collaboration - February 8, 2017
Two new Swedish industry research centres with life science focus
The Swedish Foundation for Strategic Research (SSF) is investing 400 million SEK in four industrial research centres, and two of these are focusing on challenges within life science; nucleotide based drugs and personalized diabetes medicine. SSF has decided to establish four industry research centres with the purpose to enable groundbreaking innovation coming from external industrial challenges. […]
